Abstract
A mammalian mutant MAP kinase, D319N ERK2, analogous to Drosophila melanogaster sevenmaker (rlsem) gain‐of‐function mutation was shown to have an increased sensitivity to low levels of signalling in vivo. However, the mutation does not lead to an elevated basal kinase activity and still requires activation by MAP kinase kinase (MAPKK) as does wild type ERK2. This increased responsiveness seen in vivo is not due to an increased ability to phosphorylate substrates but appears to reflect a reduced sensitivity to a MAP kinase phosphatase CL100.
References
43
Referenced
87
10.1073/pnas.90.13.5889
10.1016/0959-437X(94)90095-7
10.1016/S0021-9258(18)38072-4
10.1016/0092-8674(93)90666-E
10.1002/j.1460-2075.1992.tb05492.x
10.1038/353670a0
10.1016/0092-8674(93)90237-K
10.1016/S0021-9258(18)54312-X
10.1128/MCB.12.3.915
10.1016/0959-437X(94)90092-2
10.1016/0959-437X(94)90093-0
10.1038/335275a0
10.1038/338478a0
10.1101/gad.4.11.1835
{'key': 'e_1_2_1_16_1', 'first-page': '352', 'author': 'Kramer H.', 'year': '1991', 'journal-title': 'Nature'}
/ Nature by Kramer H. (1991)10.1016/0092-8674(84)90437-9
10.1101/gad.7.4.621
10.1016/0092-8674(93)90146-H
10.1016/0092-8674(92)90167-B
10.1126/science.8493579
{'key': 'e_1_2_1_22_1', 'first-page': '3081', 'volume': '8', 'author': 'Liu B.X.', 'year': '1993', 'journal-title': 'Oncogene'}
/ Oncogene by Liu B.X. (1993)10.1038/369411a0
10.1126/science.7811320
10.1016/0092-8674(92)90361-F
10.1038/358417a0
10.1002/j.1460-2075.1994.tb06424.x
10.1038/353170a0
10.1002/j.1460-2075.1992.tb05271.x
10.1016/0092-8674(94)90362-X
10.1002/j.1460-2075.1994.tb06426.x
10.1093/genetics/123.4.771
10.1084/jem.164.5.1478
10.1016/S0021-9258(19)36838-3
10.1002/j.1460-2075.1992.tb05088.x
10.1128/MCB.7.8.2745
- 1972 Cold Spring Harbor Laboratory Cold Spring Harbor New York J.H. Miller Experiments in Molecular Genetics
10.1016/0092-8674(94)90133-3
10.1101/gad.6.4.545
{'key': 'e_1_2_1_40_1', 'first-page': '2015', 'volume': '8', 'author': 'Alessi D.R.', 'year': '1993', 'journal-title': 'Oncogene'}
/ Oncogene by Alessi D.R. (1993)10.1016/0092-8674(93)90383-2
10.1126/science.7681221
10.1038/359644a0
{'key': 'e_1_2_1_44_1', 'first-page': '187', 'volume': '7', 'author': 'Charles C.', 'year': '1992', 'journal-title': 'Oncogene'}
/ Oncogene by Charles C. (1992)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 25, 2002, 5:09 a.m.) |
Deposited | 1 year, 11 months ago (Sept. 17, 2023, 1:48 a.m.) |
Indexed | 1 month, 4 weeks ago (July 2, 2025, 11:57 a.m.) |
Issued | 30 years, 11 months ago (Sept. 26, 1994) |
Published | 30 years, 11 months ago (Sept. 26, 1994) |
Published Online | 23 years, 10 months ago (Oct. 19, 2001) |
Published Print | 30 years, 11 months ago (Sept. 26, 1994) |
@article{Bott_1994, title={The sevenmaker gain‐of‐function mutation in p42 MAP kinase leads to enhanced signalling and reduced sensitivity to dual specificity phosphatase action}, volume={352}, ISSN={1873-3468}, url={http://dx.doi.org/10.1016/0014-5793(94)00958-9}, DOI={10.1016/0014-5793(94)00958-9}, number={2}, journal={FEBS Letters}, publisher={Wiley}, author={Bott, Cynthia M. and Thorneycroft, Simon G. and Marshall, Christopher J.}, year={1994}, month=sep, pages={201–205} }